The new inhaler replaces Trixeo Aerosphere’s existing gas propellant with a low global warming-potential alternative.

SIGNIFICANT EVENTS DURING 1 APRIL - 30 JUNE 2025In April, Iconovo announced an organizational change expected to reduce annual costs by approximately 14-16 MSEK starting in the third quarter of 2025.

Airsupra (albuterol and budesonide) is a brand-name inhaler that doctors may prescribe to treat asthma in adults. It does not have a generic version. Medicare Part D prescription drug plans may ...

TheInhalation and Nasal Spray Generic Drugs Strategic Research Report 2024-2030: Rising Demand for Cost-effective Treatment Options and Combination Inhalers - ResearchAndMarkets.com ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD exacerbations and pneumonia risk.

FRIDAY, Jan. 3, 2025 (HealthDay News) -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with ...

The main issue is that budesonide-glycopyrrolate-formoterol is a twice-daily metered-dose inhaler that can benefit COPD patients -- some older studies suggested a lower risk of less pneumonia ...

For longer-term relief from seasonal congestion, itching, and sneezing, doctors often recommend nasal steroids such as Flonase, Nasacort, and Rhinocort.

Researchers assessed how Salbutamol Easyhaler DPI compared with Ventolin Evohaler pMDI in treating MC-induced bronchoconstriction in asthma.